Intensive glucose control and macrovascular outcomes in type 2 diabetes.

Intensive glucose control and macrovascular outcomes in type 2 diabetes.

AIMS/HYPOTHESIS: Improved glucose control in type 2 diabetes is known to reduce the risk of microvascular events. There is, however, continuing uncertainty about its impact on macrovascular disease. The aim of these analyses was to generate more precise estimates of the effects of more-intensive, c...

Πλήρης περιγραφή

Λεπτομέρειες βιβλιογραφικής εγγραφής
Κύριοι συγγραφείς:	Turnbull, F, Abraira, C, Anderson, R, Byington, R, Chalmers, J, Duckworth, W, Evans, G, Gerstein, H, Holman, R, Moritz, T, Neal, B, Ninomiya, T, Patel, A, Paul, S, Travert, F, Woodward, M
Μορφή:	Journal article
Γλώσσα:	English
Έκδοση:	2009

Παρόμοια τεκμήρια

Combined effects of routine blood pressure lowering and intensive glucose control on macrovascular and microvascular outcomes in patients with type 2 diabetes: New results from the ADVANCE trial.
ανά: Zoungas, S, κ.ά.
Έκδοση: (2009)

Microvascular and macrovascular disease in subjects with increased but not diabetic fasting glucose levels
ανά: Karunakaran, S, κ.ά.
Έκδοση: (1996)

The effects of intensive glucose control on microvascular outcomes in patients with type 2 diabetes: a meta-analysis of individual participant data from randomised controlled trials
ανά: Zoungas, S, κ.ά.
Έκδοση: (2017)

Microvascular and macrovascular disease and risk for major peripheral arterial disease in patients with type 2 diabetes
ανά: Woodward, M, κ.ά.
Έκδοση: (2016)

Visit-to-visit Variability of Systolic Blood Pressure Predicts Macrovascular and Microvascular Events in Patients with Type 2 Diabetes: the ADVANCE Trial
ανά: Hata, J, κ.ά.
Έκδοση: (2012)

Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes.
ανά: Patel, A, κ.ά.
Έκδοση: (2008)

Effects of visit-to-visit variability in systolic blood pressure on macrovascular and microvascular complications in patients with type 2 diabetes mellitus: the ADVANCE trial.
ανά: Hata, J, κ.ά.
Έκδοση: (2013)

Effects of visit-to-visit variability in systolic blood pressure on macrovascular and microvascular complications in patients with type 2 diabetes mellitus: The advance trial
ανά: Hata, J, κ.ά.
Έκδοση: (2013)

Comparative effects of microvascular and macrovascular disease on the risk of major outcomes in patients with type 2 diabetes
ανά: Mohammedi, K, κ.ά.
Έκδοση: (2017)

FPG and HbA(1c) are independent risk factors for microvascular but not macrovascular complications in newly diagnosed type 2 diabetes
ανά: Kim, J, κ.ά.
Έκδοση: (2005)

Impact of the metabolic syndrome on macrovascular and microvascular outcomes in type 2 diabetes mellitus: United Kingdom Prospective Diabetes Study 78.
ανά: Cull, C, κ.ά.
Έκδοση: (2007)

Envolvimento macrovascular e esclerose sistêmica Macrovascular involvement and systemic sclerosis
ανά: Emmanuelle Tenório Albuquerque Madruga Godoi, κ.ά.
Έκδοση: (2009-03-01)

Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study.
ανά: Stratton, I, κ.ά.
Έκδοση: (2000)

Glycemic control and macrovascular disease in types 1 and 2 diabetes mellitus: Meta-analysis of randomized trials.
ανά: Stettler, C, κ.ά.
Έκδοση: (2006)

Effects of intensive blood pressure lowering on cardiovascular and renal outcomes: a systematic review and meta-analysis
ανά: Lv, J, κ.ά.
Έκδοση: (2012)

Mean platelet volume (MPV) as new marker of diabetic macrovascular complications in patients with different glucose homeostasis
ανά: Velia Cassano, κ.ά.
Έκδοση: (2024-03-01)

Micro- and Macrovascular Complications in Diabetes Mellitus: Preclinical and Clinical Studies
ανά: Érika B. Rangel, κ.ά.
Έκδοση: (2019-01-01)

Follow-up of Intensive Glucose Control in Type 2 Diabetes Reply
ανά: Holman, R, κ.ά.
Έκδοση: (2009)

Healthy lifestyle factors and combined macrovascular and microvascular events in diabetes patients with high cardiovascular risk: results from ADVANCE
ανά: Shoujiang You, κ.ά.
Έκδοση: (2025-02-01)

Type 2 Diabetes Mellitus and Macrovascular Complications
ανά: Peng-Fei Shan, κ.ά.
Έκδοση: (2017-01-01)

Association of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes (UKPDS 36): prospective observational study.
ανά: Adler, A, κ.ά.
Έκδοση: (2000)

Do men and women respond differently to blood pressure-lowering treatment? Results of prospectively designed overviews of randomized trials.
ανά: Turnbull, F, κ.ά.
Έκδοση: (2008)

Exploring Mechanisms of Diabetes-Related Macrovascular Complications: Role of Methylglyoxal, a Metabolite of Glucose on Regulation of Vascular Contractility
ανά: Masashi Mukohda, κ.ά.
Έκδοση: (2012-01-01)

Circulating amino acids and the risk of macrovascular, microvascular and mortality outcomes in individuals with type 2 diabetes: results from the ADVANCE trial
ανά: Welsh, P, κ.ά.
Έκδοση: (2018)

Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): a randomised controlled trial.
ανά: Patel, A, κ.ά.
Έκδοση: (2007)

Molecular Mechanisms of Methylglyoxal in Diabetes-related Macrovascular Complications
ανά: Anna Meiliana, κ.ά.
Έκδοση: (2024-10-01)

Microvasular and macrovascular complications in diabetes mellitus: Distinct or continuum?
ανά: Aastha Chawla, κ.ά.
Έκδοση: (2016-01-01)

10-year follow-up of intensive glucose control in type 2 diabetes.
ανά: Holman, R, κ.ά.
Έκδοση: (2008)

Effects of intensive blood pressure lowering on cardiovascular and renal outcomes: a systematic review and meta-analysis.
ανά: Jicheng Lv, κ.ά.
Έκδοση: (2012-01-01)

Association of HbA1c levels with vascular complications and death in patients with type 2 diabetes: evidence of glycaemic thresholds
ανά: Zoungas, S, κ.ά.
Έκδοση: (2012)

Diabetic microvascular complications: possible targets for improved macrovascular outcomes
ανά: Bijan Roshan, κ.ά.
Έκδοση: (2010-12-01)

Epidemiology of Micro- and Macrovascular Complications of Type 2 Diabetes in Korea
ανά: Jung Hee Kim, κ.ά.
Έκδοση: (2011-12-01)

Potential benefit of (-)-epigallocatechin-3-gallate for macrovascular complications in diabetes
ανά: L. Tang, κ.ά.
Έκδοση: (2017-08-01)

Comprehensive elaboration of glycemic variability in diabetic macrovascular and microvascular complications
ανά: Bao Sun, κ.ά.
Έκδοση: (2021-01-01)

HIV‐Associated Cardiovascular Disease: Beyond the Macrovascular
ανά: Ashley B. Pournamdari, κ.ά.
Έκδοση: (2023-11-01)

Symposium 13: Impact of prediabetes on macrovascular disease
ανά: Carolina Gómez Martin
Έκδοση: (2022-09-01)

Intensive glucose control improves kidney outcomes in patients with type 2 diabetes.
ανά: Perkovic, V, κ.ά.
Έκδοση: (2013)

Supramaximal vs functional high-intensity interval training effects on macrovascular reactivity in young male athletes
ανά: Witid Mitranun
Έκδοση: (2018-06-01)

Association between diabetic nephropathy and other diabetic microvascular and macrovascular complications
ανά: Chandy Anila, κ.ά.
Έκδοση: (2008-01-01)

Estimating individual beneficial and adverse effects of intensive glucose control for patients with type 2 diabetes
ανά: Woodward, M, κ.ά.
Έκδοση: (2016)